Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Virtual app to support breast and colorectal cancer survivors

Official title: Testing the Feasibility of a Virtual Application to Support Breast and Colorectal Cancer Survivors After Completing Primary Treatment

Run by Nova Scotia Health Authority · NCT07312786 · Data updated 2026-11-12

This study will test whether a mobile app helps breast and colorectal cancer survivors after primary treatment manage follow-up care and find community and health-system resources.

More Cancer Survivors trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment60 (estimated)
SponsorNova Scotia Health Authority
Academic / other
Drugs / interventionsradiation
Locations2 sites (Saint John, New Brunswick and 1 other locations)
StatusRecruiting
StartedApril 20, 2026
Main results expectedDecember 2026
Study endsDecember 2027
Registry record updatedMay 14, 2026
Trial IDNCT07312786 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (18+) diagnosed with stage I–III breast or colorectal cancer who completed primary treatment (surgery and/or adjuvant systemic or radiation therapy) between 6 months and 5 years ago and can provide informed consent are ideal candidates.

Probably not a fit

Patients with metastatic disease, those still within 6 months of completing primary treatment, or people who cannot access or use a smartphone/internet are unlikely to benefit from this intervention.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Developed with SeamlessMD, the intervention is a mobile health application that serves as an information hub delivering timely, evidence-based guidance and links to resources for people after primary cancer treatment. The project is a feasibility implementation at two Atlantic Canadian cancer centres (Halifax QEII and Saint John Regional Hospital) where participants will have access to the app for six months. Researchers will collect user and provider feedback and completion of questionnaires to measure usability, acceptability, and practical issues with deployment. Findings will inform whether the app can be scaled or modified for broader survivorship care.

Why it matters

Potential benefit: If successful, the app could improve survivors' communication with care teams, help people follow recommended surveillance and self-management practices, and connect them to local supports.

How similar studies have gone: Other digital survivorship and care-navigation tools, including SeamlessMD deployments in perioperative and oncology settings, have shown promise for engagement and information delivery, but evidence of large effects on long-term clinical outcomes is still limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adults older than 18 years, capable of providing informed consent
* Diagnosed with stage I-III breast or colorectal cancer, and have completed primary treatment for their cancer (surgery and/or adjuvant systemic or radiation therapy) 6 months - 5 years ago

Where it's running

  • Centre for Clinical Research QEII Health Sciences Centre
    Halifax, Nova Scotia, Canada
    Recruiting
  • Saint John Regional Hospital
    Saint John, New Brunswick, Canada
    Not yet recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.